| eBank
(potential) generic solution |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| • | During Phase 1
eBank has focussed |
|||||||||||||
| exclusively on
the chemistry domain |
||||||||||||||
| and in
particular within the area of |
||||||||||||||
| crystallography. |
||||||||||||||
| • | Potential to
expand remit to: |
|||||||||||||
| – | wider range of
crystallographic data |
|||||||||||||
| – | other chemistry
sub-domains (e.g., |
|||||||||||||
| combinational
chemistry) |
||||||||||||||
| – | Other sciences,
e.g., bioinformatics, physical |
|||||||||||||
| sciences |
||||||||||||||